日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

International Center-Level Variation in Utilization of Completion Lymph Node Dissection and Adjuvant Systemic Therapy for Sentinel Lymph Node-Positive Melanoma at Major Referral Centers

国际上各主要转诊中心在哨兵淋巴结阳性黑色素瘤患者中实施淋巴结清扫术和辅助全身治疗的利用率方面的差异

Broman, Kristy K; Hughes, Tasha M; Bredbeck, Brooke C; Sun, James; Kirichenko, Dennis; Carr, Michael J; Sharma, Avinash; Bartlett, Edmund K; Nijhuis, Amanda A G; Thompson, John F; Hieken, Tina J; Kottschade, Lisa; Downs, Jennifer; Gyorki, David E; Stahlie, Emma; van Akkooi, Alexander; Ollila, David W; O'shea, Kristin; Song, Yun; Karakousis, Giorgos; Moncrieff, Marc; Nobes, Jenny; Vetto, John; Han, Dale; Hotz, Meghan; Farma, Jeffrey M; Deneve, Jeremiah L; Fleming, Martin D; Perez, Matthew; Baecher, Kirsten; Lowe, Michael; Bagge, Roger Olofsson; Mattsson, Jan; Lee, Ann Y; Berman, Russell S; Chai, Harvey; Kroon, Hidde M; Teras, Juri; Teras, Roland M; Farrow, Norma E; Beasley, Georgia M; Hui, Jane Yuet Ching; Been, Lukas; Kruijff, Schelto; Sinco, Brandy; Sarnaik, Amod A; Sondak, Vernon K; Zager, Jonathan S; Dossett, Lesly A

Outcomes with adjuvant anti-PD-1 therapy in patients with sentinel lymph node-positive melanoma without completion lymph node dissection

辅助抗PD-1治疗对未行淋巴结清扫术的前哨淋巴结阳性黑色素瘤患者的疗效

Eroglu, Zeynep; Broman, Kristy K; Thompson, John F; Nijhuis, Amanda; Hieken, Tina J; Kottschade, Lisa; Farma, Jeffrey M; Hotz, Meghan; Deneve, Jeremiah; Fleming, Martin; Bartlett, Edmund K; Sharma, Avinash; Dossett, Lesly; Hughes, Tasha; Gyorki, David E; Downs, Jennifer; Karakousis, Giorgos; Song, Yun; Lee, Ann; Berman, Russell S; van Akkooi, Alexander; Stahlie, Emma; Han, Dale; Vetto, John; Beasley, Georgia; Farrow, Norma E; Hui, Jane Yuet Ching; Moncrieff, Marc; Nobes, Jenny; Baecher, Kirsten; Perez, Matthew; Lowe, Michael; Ollila, David W; Collichio, Frances A; Bagge, Roger Olofsson; Mattsson, Jan; Kroon, Hidde M; Chai, Harvey; Teras, Jyri; Sun, James; Carr, Michael J; Tandon, Ankita; Babacan, Nalan Akgul; Kim, Younchul; Naqvi, Mahrukh; Zager, Jonathan; Khushalani, Nikhil I

Neoadjuvant nivolumab + T-VEC combination therapy for resectable early stage or metastatic (IIIB-IVM1a) melanoma with injectable disease: study protocol of the NIVEC trial

新辅助纳武利尤单抗联合T-VEC治疗可切除的早期或转移性(IIIB-IVM1a)黑色素瘤伴注射病灶:NIVEC试验研究方案

Rohaan, Maartje W; Stahlie, Emma H A; Franke, Viola; Zijlker, Lisanne P; Wilgenhof, Sofie; van der Noort, Vincent; van Akkooi, Alexander C J; Haanen, John B A G

T-VEC for stage IIIB-IVM1a melanoma achieves high rates of complete and durable responses and is associated with tumor load: a clinical prediction model

T-VEC方案治疗IIIB-IVM1a期黑色素瘤可获得较高的完全缓解率和持久缓解率,且与肿瘤负荷相关:临床预测模型

Stahlie, Emma H A; Franke, Viola; Zuur, Charlotte L; Klop, Willem M C; van der Hiel, Bernies; Van de Wiel, Bart A; Wouters, Michel W J M; Schrage, Yvonne M; van Houdt, Winan J; van Akkooi, Alexander C J

Active surveillance of patients who have sentinel node positive melanoma: An international, multi-institution evaluation of adoption and early outcomes after the Multicenter Selective Lymphadenectomy Trial II (MSLT-2)

对前哨淋巴结阳性黑色素瘤患者进行主动监测:多中心选择性淋巴结切除试验 II (MSLT-2) 后采用情况和早期结果的国际多机构评估

Broman, Kristy Kummerow; Hughes, Tasha; Dossett, Lesly; Sun, James; Kirichenko, Dennis; Carr, Michael J; Sharma, Avinash; Bartlett, Edmund K; Nijhuis, Amanda A G; Thompson, John F; Hieken, Tina J; Kottschade, Lisa; Downs, Jennifer; Gyorki, David E; Stahlie, Emma; van Akkooi, Alexander; Ollila, David W; Frank, Jill; Song, Yun; Karakousis, Giorgos; Moncrieff, Marc; Nobes, Jenny; Vetto, John; Han, Dale; Farma, Jeffrey M; Deneve, Jeremiah L; Fleming, Martin D; Perez, Matthew C; Lowe, Michael C; Olofsson Bagge, Roger; Mattsson, Jan; Lee, Ann Y; Berman, Russell S; Chai, Harvey; Kroon, Hidde M; Teras, Juri; Teras, Roland M; Farrow, Norma E; Beasley, Georgia; Hui, Jane Yuet Ching; Been, Lukas; Kruijff, Schelto; Kim, Youngchul; Naqvi, Syeda Mahrukh Hussnain; Sarnaik, Amod A; Sondak, Vernon K; Zager, Jonathan S

Surveillance of Sentinel Node-Positive Melanoma Patients with Reasons for Exclusion from MSLT-II: Multi-Institutional Propensity Score Matched Analysis

对因各种原因被排除在MSLT-II研究之外的前哨淋巴结阳性黑色素瘤患者进行监测:多中心倾向评分匹配分析

Broman, Kristy K; Hughes, Tasha M; Dossett, Lesly A; Sun, James; Carr, Michael J; Kirichenko, Dennis A; Sharma, Avinash; Bartlett, Edmund K; Nijhuis, Amanda Ag; Thompson, John F; Hieken, Tina J; Kottschade, Lisa; Downs, Jennifer; Gyorki, David E; Stahlie, Emma; van Akkooi, Alexander; Ollila, David W; Frank, Jill; Song, Yun; Karakousis, Giorgos; Moncrieff, Marc; Nobes, Jenny; Vetto, John; Han, Dale; Farma, Jeffrey; Deneve, Jeremiah L; Fleming, Martin D; Perez, Matthew; Baecher, Kirsten; Lowe, Michael; Bagge, Roger Olofsson; Mattsson, Jan; Lee, Ann Y; Berman, Russell S; Chai, Harvey; Kroon, Hidde M; Teras, Roland M; Teras, Juri; Farrow, Norma E; Beasley, Georgia M; Hui, Jane Yc; Been, Lukas; Kruijff, Schelto; Boulware, David; Sarnaik, Amod A; Sondak, Vernon K; Zager, Jonathan S

False positive FDG uptake in melanoma patients treated with talimogene laherparepvec (T-VEC)

接受 talimogene laherparepvec (T-VEC) 治疗的黑色素瘤患者出现 FDG 摄取假阳性

Mulder, Evalyn E A P; Stahlie, Emma H A; Verver, Daniëlle; Lemstra, Clara; Been, Lukas B; Mooyaart, Antien L; Brabander, Tessa; Vegt, Erik; Verburg, Frederik A; van der Veldt, Astrid A M; Verhoef, Cornelis; van Akkooi, Alexander C J; Grünhagen, Dirk J